Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors

Cancer is associated with alterations in epigenetic mechanisms such as histone modifications and methylation of DNA, and inhibitors targeting epigenetic mechanisms represent a novel class of anti-cancer drugs. Neuroendocrine tumors (NETs) of the pancreas (PNETs) and bronchus (BNETs), which may have...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncogenesis
Главные авторы: Lines, K E, Stevenson, M, Filippakopoulos, P, Müller, S, Lockstone, H E, Wright, B, Grozinsky-Glasberg, S, Grossman, A B, Knapp, S, Buck, D, Bountra, C, Thakker, R V
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523063/
https://ncbi.nlm.nih.gov/pubmed/28504695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2017.30
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы